Results 61 to 70 of about 2,284,885 (351)

Blood and blood products to support allogeneic hematopoietic progenitor cell transplant recipients at king abdulaziz medical city-Riyadh – Transfusion medicine services

Journal of Applied Hematology, 2022
Hematopoietic progenitor cell transplant (HPCT) is found throughout the body. HPCT is a set of undifferentiated cells that are capable of indefinite self-renewal and generation of a functional progeny of highly specialized cells. Allogeneic HPCT presents
Ahmed Al Harbi, Abdullah Al-Anazi, Faisal Al Saqri, Haya Wasel   +3 more
doaj   +1 more source

Central Nervous System Tumors Among Infants in Canada: A Report From CYP‐C

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Central nervous system (CNS) tumors in infants are rare, pose unique clinical challenges, and lack large‐scale evidence‐based data to guide management. This study seeks to describe CNS tumors in Canadian infants and to compare their outcomes with those of older children.
Samuel Sassine, Hallie Coltin, Sylvia Cheng, Lucie Lafay‐Cousin, Vanan Issai Magimairajan, Craig Erker, Stéphanie Vairy, Lynette Bowes, Adam Fleming, Donna Johnston, Sarah McKillop, Roona Sinha, Julie Bennett, Christina Coleman, Laura Wheaton, Shayna Zelcer, Samuele Renzi, Thai Hoa Tran   +17 more
wiley   +1 more source

How small is too small? A systematic review of center volume and outcome after cardiac transplantation [PDF]

, 2012
Background—The aim of this study was to assess the relationship between the volume of cardiac transplantation procedures performed in a center and the outcome after cardiac transplantation.
Hawkins, N.M., Petrie, M.C., Pettit, S.J., McMurray, J.J.V., Haj-Yahia, S., Gardner, R.S., Jhund, P.S.   +6 more
core   +1 more source

Revisiting Stem Cell-Based Clinical Trials for Ischemic Stroke

Frontiers in Aging Neuroscience, 2020
Stroke is the leading cause of serious long-term disability, significantly reducing mobility in almost half of the affected patients aged 65 years and older. There are currently no proven neurorestorative treatments for chronic stroke.
Joy Q. He, Eric S. Sussman, Gary K. Steinberg, Gary K. Steinberg, Gary K. Steinberg   +4 more
doaj   +1 more source

The Application of the Iliac Artery in the Ex Vivo Reconstruction of Renal Arteries in Renal Transplantation: Retraction.

Transplantation, 2019
REFERENCES 1. Zheng SS, Xu X, Wu J, et al. Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation 2008;85:1726–32 2. Chapman JR, Stock P, Haberal M.

semanticscholar   +1 more source

Comparative Drug Response Profiling in Neuroblastoma Cell Lines and Patient‐Derived Tumor Organoids

Pediatric Blood &Cancer, EarlyView.
ABSTRACT High‐risk neuroblastoma remains a leading cause of pediatric cancer mortality, and improved preclinical models are needed to guide therapeutic developments. We screened seven high‐risk neuroblastoma cell lines and three patient‐derived tumor organoids with 528 compounds alongside bone marrow controls, and compared them with external datasets ...
Krzysztof Wierbiłowicz, Se Whee Sammy Park, Aironas Los, Ernest Liu, Nona Struyf, Tom Erkers, Sören Lehmann, Jan J. Molenaar, Jakob Stenman, Olli Kallioniemi, Päivi Östling, Brinton Seashore‐Ludlow, Kasper Karlsson   +12 more
wiley   +1 more source

Retrospective Analysis of Donor Lymphocyte Infusions in Pediatric Patients With Mixed Chimerism After Hematopoietic Stem Cell Transplantation

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk, Sebastian Michaelis, Michaela Döring, Thomas Eichholz, Ursula Holzer, Martin Ebinger, Tim Flaadt, Rupert Handgretinger, Peter Lang, Jan Frederic Weller, Markus Mezger   +10 more
wiley   +1 more source

Anesthesia and Critical Care for the Prediction and Prevention for Small-for-size Syndrome: Guidelines from the ILTS-iLDLT-LTSI Consensus Conference

, 2023
BACKGROUND: During the perioperative period of living donor liver transplantation, anesthesiologists and intensivists may encounter patients in receipt of small grafts that puts them at risk of developing small for size syndrome (SFSS).
Egawa, H., Humar, A., Clavien, Pierre-Alain, Rammohan, Ashwin, Shah, Samir, Ascher, N., Clavien, P. A., Lerut, Jan, Rajakumar, A., Cattral, M., Sun, L. Y., Saigal, S., Clemens Broering, D., Kumar, Lakshmi, Clemens Broering, Dieter, Chen, Chao-Long, Bezinover, Dmitri, Findlay, J., Yi, Nam-Joon, Yoon, U., Spiro, Michael, Egawa, Hiroto, Patel, D., Yi, N. J., Kumar, L., Agarwal, Shaleen, Patel, Dhupal, Sun, Li-Ying, Humar, Abhinav, Singh, Shweta, Bhangui, P., Rajakumar, Akila, Yoon, Uzung, Kumaran, Vinay, Lerut, J., Rammohan, A., Shingina, Alexandra, Shingina, A., Bhangui, Prashant, Singh, S., Berlakovich, G., Emond, J., Chadha, Ryan, Zhu, Z. J., Saigal, Sanjiv, Chen, C. L., Rela, M., Rodriguez-Davalos, M., Sakai, Tetsuro, Bezinover, D., Shah, S., Emond, Jean, Agarwal, S., Chadha, R., Ascher, Nancy, Bhangui, Pooja, Berlakovich, Gabriela, Rodriguez-Davalos, Manuel, Rela, Mohamed, Spiro, M., Zhu, Zhi-Jun, Cattral, Mark, Sakai, T., Berenguer, M., Findlay, James, Kumaran, V., Berenguer, Marina   +66 more
core   +1 more source

Annual Report of the Indian Society for Heart and Lung Transplantation Registry 2024 (INTRAN)

Journal of the Practice of Cardiovascular Sciences
This is a registry report of the Indian Society for Heart and Lung Transplantation. The data reflects thoracic transplants done in India since 1994. It is a voluntary cloud-based registry.
Indian Society for Heart and Lung Transplantation (INSHLT)
doaj   +1 more source

Venetoclax‐Based Therapy as a Bridge to Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Pediatric Acute Leukemia

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Relapsed and/or refractory (R/R) pediatric acute leukemia carries a dismal prognosis, largely driven by chemoresistance to conventional salvage therapy. The BH3‐mimetic venetoclax, combined with chemotherapy or hypomethylating agents, has demonstrated efficacy in small clinical trials.
Katherine S. Colman, Deborah Meyran, Vajiranee Malalasekera, Heather Weerdenburg, Janine Campbell, Rachel Conyers, Stacie Wang, Hannah Walker, Seong Lin Khaw, Diane Hanna   +9 more
wiley   +1 more source